|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 07804199.3 (espacenet) (Federated) (European Patent Register), 20070910 | | Patent/reg. no. and date | DK/EP 2061485, 20120822 | | Publication date | 20090527 | | Priority no. and date | GB 0617734, 20060908 | | EP pub. no. and date |
EP 2061485 20090527 | | Effective date | | | Applicant/owner | Volution Immuno Pharmaceuticals SA, Place des Eaux Vives 6
case postale 3461
1211 Geneve 3, CH | | Applicant ref. no. | 145451 | | Inventor | HAMER, John, Varleigh Limited
The Doctors Laboratory
60 Whitfield Street
London W1T 4EU, GB | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/17 (2006.01) , A61P 25/02 (2006.01) | | Title | EV576-peptider til anvendelse ved behandling af Guillain-Barré-syndrom | | Int. application no. | GB2007003401 | | Int. publication no. | WO2008029167 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
